Camfetamine (N-methyl-3-phenyl-norbornan-2-amine) is a stimulant drug closely related to the appetite suppressant fencamfamine, being its N-methyl homologue.[1] It has been sold as a designer drug following the banning of mephedrone and related substituted cathinone derivatives in many countries,[2] and reportedly has slightly stronger stimulant effects than fencamfamine, but with correspondingly more severe side effects.

See also

References

  1. ^ DE patent 1110159, Thesing J, Seitz G, Hotovy R, Sommer S, "Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate bzw. von deren Säureadditionssalzen und quaternären Ammoniumverbindungen", issued 1961-07-06, assigned to E. Merck AG 
  2. ^ Kavanagh P, Angelov D, O'Brien J, Power JD, McDermott SD, Talbot B, et al. (April 2013). "The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™)". Drug Testing and Analysis. 5 (4): 247–53. doi:10.1002/dta.411. PMID 22374810.